Bridgebio Pharma Inc
(BBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 547,367 | 475,353 | 392,588 | 521,865 | 322,368 |
| Marketable Securities | 39,813 | 44,469 | 58,949 | 38,052 | 81,356 |
| Receivables | 660 | 235,494 | 1,751 | 5,170 | 8,614 |
| TOTAL | $616,236 | $783,424 | $477,593 | $587,670 | $432,884 |
| Non-Current Assets | |||||
| PPE Net | 9,840 | 11,414 | 11,816 | 12,413 | 13,047 |
| Investments And Advances | 117,006 | 0 | 0 | 0 | 0 |
| Intangibles | 25,123 | 25,721 | 26,319 | 26,917 | 27,515 |
| Other Non-Current Assets | 26,170 | 28,774 | 30,652 | 28,008 | 30,215 |
| TOTAL | $178,139 | $65,909 | $68,787 | $67,338 | $70,777 |
| Total Assets | $794,375 | $849,333 | $546,380 | $655,008 | $503,661 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,126 | 4,728 | 10,655 | 4,472 | 3,874 |
| Accrued Expenses | 96,517 | 118,248 | 122,965 | 90,864 | 96,260 |
| TOTAL | $134,364 | $141,477 | $143,844 | $106,065 | $110,120 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,717,599 | 1,715,932 | 1,726,729 | 1,721,081 | 1,718,937 |
| Deferred Revenues | 15,098 | 13,957 | 6,096 | 6,592 | 6,210 |
| Other Non-Current Liabilities | 9,409 | 10,361 | 17,273 | 25,489 | 27,379 |
| TOTAL | $1,741,881 | $1,745,239 | $1,745,549 | $1,744,081 | $1,743,512 |
| Total Liabilities | $1,876,245 | $1,886,716 | $1,889,393 | $1,850,146 | $1,853,632 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 188,033 | 187,129 | 175,832 | 173,967 | 162,472 |
| Common Shares | 194 | 193 | 181 | 180 | 168 |
| Retained earnings | -2,669,173 | -2,595,717 | -2,560,501 | -2,392,353 | -2,215,354 |
| Other shareholders' equity | 11,051 | 12,147 | 11,275 | 12,439 | 12,115 |
| TOTAL | $-1,081,870 | $-1,037,383 | $-1,343,013 | $-1,195,138 | $-1,349,971 |
| Total Liabilities And Equity | $794,375 | $849,333 | $546,380 | $655,008 | $503,661 |